Pages that link to "Q48087981"
Jump to navigation
Jump to search
The following pages link to Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion (Q48087981):
Displaying 50 items.
- Progress on Complications of Direct Bypass for Moyamoya Disease (Q26738656) (← links)
- Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke (Q26766038) (← links)
- Dynamic regulation of aquaporin-4 water channels in neurological disorders (Q26777349) (← links)
- Bench to bedside: brain edema and cerebral resuscitation: the present and future (Q30718451) (← links)
- Brain oedema following blood-brain barrier disruption: mechanisms and diagnosis (Q30793908) (← links)
- Endoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy (Q30830869) (← links)
- Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection (Q33223756) (← links)
- Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent (Q33223989) (← links)
- Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models (Q33566724) (← links)
- Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene (Q33765867) (← links)
- Hemostasis and alterations of the central nervous system (Q33842161) (← links)
- Multiple molecular penumbras after focal cerebral ischemia (Q33977693) (← links)
- Pharmaco-proteomics opportunities for individualizing neurovascular treatment (Q34128934) (← links)
- Application of proteomics to cerebrovascular disease (Q34312457) (← links)
- The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia (Q34335614) (← links)
- Disruption of striatal-enriched protein tyrosine phosphatase (STEP) function in neuropsychiatric disorders (Q34438426) (← links)
- Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans (Q34522397) (← links)
- Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. (Q34627485) (← links)
- Role of superoxide dismutases in oxidative damage and neurodegenerative disorders (Q34795518) (← links)
- Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients. (Q35109940) (← links)
- Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside (Q35580549) (← links)
- Triggers and mediators of hemorrhagic transformation in cerebral ischemia (Q35622297) (← links)
- Progesterone is neuroprotective by inhibiting cerebral edema after ischemia (Q35969674) (← links)
- Asiatic acid attenuates infarct volume, mitochondrial dysfunction, and matrix metalloproteinase-9 induction after focal cerebral ischemia (Q35992075) (← links)
- Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion (Q36007470) (← links)
- Extracellular proteolytic pathophysiology in the neurovascular unit after stroke (Q36052713) (← links)
- Effects of maternal treatment with corticosteroids on tight junction protein expression in the cerebral cortex of the ovine fetus with and without exposure to in utero brain ischemia (Q36072853) (← links)
- Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment (Q36118307) (← links)
- Effects of deferoxamine on blood-brain barrier disruption after subarachnoid hemorrhage (Q36294154) (← links)
- Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor (Q36356869) (← links)
- Does inhibiting Sur1 complement rt-PA in cerebral ischemia? (Q36426567) (← links)
- Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway (Q36614373) (← links)
- Response of matrix metalloproteinase-9 to olfactory nerve injury (Q36670677) (← links)
- The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia (Q36690082) (← links)
- Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes (Q36700111) (← links)
- Peak in matrix metaloproteinases-2 levels observed during recovery from olfactory nerve injury (Q36720987) (← links)
- Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke (Q36802414) (← links)
- Interferon-β Modulates Inflammatory Response in Cerebral Ischemia (Q36877674) (← links)
- Reperfusion activates metalloproteinases that contribute to neurovascular injury (Q36986393) (← links)
- Endocannabinoids and reactive nitrogen and oxygen species in neuropathologies. (Q37015432) (← links)
- Malvidin's Effects on Rat Pial Microvascular Permeability Changes Due to Hypoperfusion and Reperfusion Injury. (Q37053366) (← links)
- Molecular physiology of preconditioning-induced brain tolerance to ischemia (Q37056974) (← links)
- Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice (Q37155284) (← links)
- Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice (Q37379099) (← links)
- Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. (Q37471962) (← links)
- IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions (Q37479916) (← links)
- Mmp-9 inhibition: a therapeutic strategy in ischemic stroke (Q37568882) (← links)
- Insulin-like growth factor -1 (IGF-1) derived neuropeptides, a novel strategy for the development of pharmaceuticals for managing ischemic brain injury. (Q37710673) (← links)
- Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments. (Q37712444) (← links)
- Inflammation in adult and neonatal stroke (Q37714376) (← links)